Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience

被引：8

作者：

Hultcrantz, Malin ^{[1
]}

Orozco, Jennifer ^{[2
]}

Peterson, Tim J. ^{[2
]}

Derkach, Andriy ^{[3
]}

Hassoun, Hani ^{[1
]}

Korde, Neha ^{[1
]}

Lu, Sydney X. ^{[1
]}

Mailankody, Sham ^{[1
]}

Patel, Dhwani ^{[1
]}

Shah, Urvi A. ^{[1
]}

Tan, Carlyn ^{[1
,4
]}

Maclachlan, Kylee H. ^{[1
]}

Chung, David J. ^{[5
]}

Landau, Heather J. ^{[6
]}

Shah, Gunjan L. ^{[6
]}

Lahoud, Oscar B. ^{[6
]}

Scordo, Michael ^{[6
]}

Landgren, Ola ^{[7
]}

Giralt, Sergio ^{[8
]}

Lesokhin, Alexander ^{[4
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Dept Pharm, Dept Med, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[7] Univ Miami, Dept Med, Myeloma Program, Sylvester Comprehens Canc Ctr, Miami, FL USA

[8] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-15344

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1644

引用

页数：5

共 50 条

[1] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Single Center Experience
Hultcrantz, Malin
Derkach, Andriy
Hassoun, Hani
Korde, Neha
Maclachlan, Kylee H.
Mailankody, Sham
Patel, Dhwani
Shah, Urvi A.
Tan, Carlyn
Akhlaghi, Theresia
Hamadeh, Issam S.
Chung, David J.
Lahoud, Oscar B.
Landau, Heather
Scordo, Michael
Shah, Gunjan L.
Giralt, Sergio A.
Lesokhin, Alexander M.
Usmani, Saad
[J]. BLOOD, 2022, 140 : 7246 - 7248
[2] Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma
Becnel, Melody
Ferreri, Christopher
Feng, Lei
Richards, Tiffany
Horowitz, Sandra
Patel, Nimisha
Gombos, Dan
Razmandi, Azadeh
Murga, Astrid
Seif, Sherif
Youssef, George
Murphy, Kevin
Kaufman, Gregory
Weber, Donna
Patel, Krina
Thomas, Sheeba
Manasanch, Elisabet
Orlowski, Robert
Lee, Hans
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S163 - S164
[3] Belantamab mafodotin for relapsed/refractory multiple myeloma: a real-world observational study update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S185 - S186
[4] Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
Shragai, Tamir
Magen, Hila
Lavi, Noa
Gatt, Moshe
Trestman, Svetlana
Zektser, Miri
Ganzel, Chezi
Jarchowsky, Osnat
Berger, Tamar
Tadmor, Tamar
Leiba, Merav
Hertzog-Tzarfaty, Katrin
Horowitz, Netanel
Shapira, Michael
Varssano, David
Berger, Yoav
Frenkel, Shahar
Krauthammer, Mark
Avivi, Irit
Luttwak, Efrat
Cohen, Yael C.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (01) : 45 - 53
[5] Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma: A Real-World Observational Study Update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S504 - S504
[6] Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma.
Becnel, Melody
Ferreri, Christopher J.
Feng, Lei
Richards, Tiffany Ann
Horowitz, Sandra B.
Patel, Nimisha
Gombos, Dan S.
Razmandi, Azadeh
Murga, Astrid
Seif, Sherif
Youssef, George
Murphy, Kevin
Kaufman, Gregory Peter
Weber, Donna M.
Patel, Krina K.
Thomas, Sheeba K.
Manasanch, Elisabet Esteve
Orlowski, Robert Z.
Lee, Hans C.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[7] Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma
Patel, Mihir
Locke, Susan C.
Falvey, Caroline
Troy, Jesse D.
Herring, Kris W.
Bolgioni-Smith, Amanda
Doherty, Allison
Elcock, Cherie Howard
Iadeluca, Laura L.
LeBlanc, Thomas William
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[8] Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Observational Study
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Kotowsky, Nirali
Bitetti, Jacopo
Mackay, Christine
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans C.
[J]. BLOOD, 2022, 140 : 10124 - 10126
[9] Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real-world setting: The ALFA study
Roussel, Murielle
Texier, Nathalie
Nael, Virginie
Bitetti, Jacopo
Paka, Prani
Kerbouche, Naima
Sail, Lynda
Colin, Xavier
Leleu, Xavier
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (03) : 310 - 320
[10] Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: a multi-center retrospective study
Shragai, Tamir
Magen, Hila
Lavi, Noa
Gatt, Moshe
Trestman, Svetlana
Zektser, Miri
Ganzel, Chezi
Jarchowsky, Osant
Berger, Tamar
Tadmor, Tamar
Leiba, Merav
Hertzog-Zarfaty, Katrin
Horowitz, Netanel
Shapira, Michael
Varssano, David
Berger, Yoav
Frenkel, Shahar
Krauthammer, Mark
Avivi, Irit
Luttwak, Efrat
Cohen, Yael
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S98 - S98

← 1 2 3 4 5 →